US · Healthcare

Champions Oncology Inc (CSBR)

Biotechnology

Champions Oncology Inc (CSBR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CSBR

P/E ratio

25.00

Champions Oncology Inc (CSBR) — FAQ

What is CSBR's P/E ratio?

The price-to-earnings (P/E) ratio for Champions Oncology Inc (CSBR) is 25.00 (data as of 2026-05-23).

Does Champions Oncology Inc pay a dividend?

Dividend yield is not available in the current snapshot for Champions Oncology Inc (CSBR). Check the MyAverix Finance app for the latest dividend data.

What sector is Champions Oncology Inc in?

Champions Oncology Inc (CSBR) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CSBR listed on?

CSBR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)